Difference between revisions of "Life Sciences Blueprint"
Jump to navigation
Jump to search
(Category overhaul (approved)) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 11: | Line 11: | ||
*[[John Aston]] from [[Astex Therapeutics]] | *[[John Aston]] from [[Astex Therapeutics]] | ||
*[[Chris Brinsmead]] from [[AstraZeneca]] | *[[Chris Brinsmead]] from [[AstraZeneca]] | ||
| + | *[[ABPI]] | ||
| + | *[[BIA]] | ||
| + | *[[ABHI]] | ||
| + | *[[BIVDA]] | ||
==Contact== | ==Contact== | ||
| Line 36: | Line 40: | ||
[[Category:GM]][[Category:Biotechnology]][[Category:Big Pharma]] | [[Category:GM]][[Category:Biotechnology]][[Category:Big Pharma]] | ||
| + | [[Category:Pharmaceutical Industry]] | ||
Latest revision as of 13:55, 17 October 2026
|
This article is part of the Pharma_Portal project of Spinwatch. |
People and Affiliations[1]
- Peter Mandelson
- Andy Burnham
- Lord Drayson
- David Brickwood from Johnson & Johnson
- Subhanu Saxena from Novartis
- John Aston from Astex Therapeutics
- Chris Brinsmead from AstraZeneca
- ABPI
- BIA
- ABHI
- BIVDA
Contact
The Life Sciences Blueprint was launched by the Office for Life Sciences (OLS), which is comprised of officials from BIS (Department for Innovation and Skills) and the Department of Health.
Address
- BIS
- Castle View House
- East Lane
- Runcorn
- WA7 2GJ
Phone:
- 020 7215 5555
Email:
- info@dius.gsi.gov.uk
Website: http://www.dius.gov.uk/ols
Notes
- ↑ Office for Life Sciences. Life Sciences Blueprint Accessed 20 July 2009.